New inhaled TB drug shows promise in early trial
Disease control
Recruiting now
This study tests a new inhaled medicine called RESP30TB in 24 adults with newly diagnosed, drug-sensitive tuberculosis of the lungs. The main goal is to see if the drug is safe and how well it kills TB bacteria in the early days of treatment. Participants will inhale the drug and…
Phase: PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated May 11, 2026 20:47 UTC